Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase NA 2

Status

Unknown 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3

Conditions

Leukemia, Myeloid, Acute 3

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 85Paclitaxel 78Fluorouracil 78Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 65Doxorubicin 60Oxaliplatin 59Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 30Epirubicin 29Neoadjuvant Therapy 28Pemetrexed 27Tamoxifen 25Prednisone 24Irinotecan 24Rituximab 21Methotrexate 21Radiotherapy, Intensity-Modulated 19apatinib 18Vinorelbine 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Aclarubicin × Clear all
NCT05382390 2022-05-19

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial

Shengjing Hospital

Phase 3 Unknown
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04716114 2021-11-02

ALIVE

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Phase 3 Unknown
315 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04083911 2019-09-10

Study of DAC Combined With HAAG Regimen in Newly Diagnosed AML Patients Older Than 60

The First Affiliated Hospital of Soochow University

Phase 3 Unknown
50 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡